Genomics in Scotland strategy: business and regulatory impact assessment

Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).


13. Implementation and Delivery Plan, including post-implementation review

Governance and progress will be overseen by the Scottish Government, with progress reports published annually. The SSNGM, with an oversight board, steering group and patient involvement advisory group, will provide expertise, support, and advice on actions and general direction of travel. Responsibility for delivery of actions will sit across many delivery partners including the Scottish Government, NHS Boards and the SSNGM. The ‘Once for Scotland’ approach will be a core principle with national decisions and implementation made wherever possible for work that is universally applicable across Scotland.

Further detail of each phase of implementation will be published throughout the term of the strategy, with the initial one-year implementation plan available alongside the launch of the strategy.

Contact

Email: holly.ennis@gov.scot

Back to top